Ranjit S. Chadha - 08 Jul 2022 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
11 Jul 2022, 16:34:30 UTC
Prior SEC filing
11 Apr 2022
Next SEC filing
03 Apr 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Dane Baumgardner, Attorney-In-Fact for Ranjit S. Chadha

Key filing fact

Ranjit S. Chadha filed Form 4 for DENTSPLY SIRONA Inc. (XRAY) on 11 Jul 2022.

Key facts

  • This page summarizes Ranjit S. Chadha's Form 4 filing for DENTSPLY SIRONA Inc. (XRAY).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 11 Jul 2022, 16:34.

Change

  • Previous filing in this sequence was filed on 11 Apr 2022.
  • Current net transaction value: +$57.44.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

XRAY transaction

Common Stock

Award

Transaction value
$0
Shares
+8
Change %
+0.29%
Price
$0.000000
Shares after
2,755
Date
08 Jul 2022
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

XRAY transaction Derivative

Phantom Stock (Supplemental Executive Retirement Plan) SERP

Award

Transaction value
$57.44
Shares
+2
Change %
+0.35%
Price
$35.52
Shares after
461
Date
08 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2
Exercise price
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.

Footnote F2

Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment.

Footnote F3

Comprised of phantom stock acquired as a result of accrued dividends.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .